Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | NVCT | AVXL | ||
| Company | Editas Medicine | Nuvectis Pharma Inc | Anavex Lf SC | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.05 | 10.98 | 3.24 | ||
| High | 3.08 | 11.09 | 3.30 | ||
| Low | 2.90 | 10.38 | 3.02 | ||
| Latest | 2.93 | 10.90 | 3.06 | ||
| Change | -0.13 | -0.16 | -0.18 | ||
| % Change | -4.25% | -1.45% | -5.56% | ||
| Volume | 1,020,900 | 96,000 | 1,236,100 | ||
| 20-Day Average Volume | 1,312,335 | 76,590 | 869,815 | ||
| Previous Close | 3.06 | 11.06 | 3.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.13 | 9.24 | 3.35 | ||
| 20-Day Raw Stochastic | 18.18% | 73.61% | 6.08% | ||
| 20-Day Relative Strength | 51.31 | 66.78 | 41.07 | ||
| Weighted Alpha | +52.00 | +13.53 | -40.28 | ||
| Today's Opinion | 64% Buy | 100% Buy | 100% Sell | ||
| Previous Opinion | 64% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 24% Buy | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.62% since 05/05/26 | +12.26% since 05/05/26 | -8.93% since 05/05/26 | ||
| Low | 2.90 on 05/12/26 | 9.44 on 05/06/26 | 3.02 on 05/12/26 | ||
| High | 3.27 on 05/11/26 | 11.85 on 05/11/26 | 3.39 on 05/07/26 | ||
| 1-Month | |||||
| %Chg | -0.34% since 04/10/26 | +32.60% since 04/10/26 | +3.73% since 04/10/26 | ||
| Low | 2.77 on 04/29/26 | 8.13 on 04/13/26 | 2.93 on 04/13/26 | ||
| High | 3.65 on 04/20/26 | 11.85 on 05/11/26 | 3.76 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +74.40% since 02/12/26 | +23.86% since 02/12/26 | -21.94% since 02/12/26 | ||
| Low | 1.67 on 02/19/26 | 7.17 on 03/30/26 | 2.61 on 03/25/26 | ||
| High | 3.65 on 04/20/26 | 11.85 on 05/11/26 | 5.18 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +8.52% since 11/12/25 | +81.36% since 11/12/25 | -55.65% since 11/12/25 | ||
| Low | 1.66 on 02/05/26 | 5.77 on 12/02/25 | 2.61 on 03/25/26 | ||
| High | 3.65 on 04/20/26 | 11.85 on 05/11/26 | 7.25 on 11/13/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 286,865 | 289,133 | 283,576 | ||
| Shares Outstanding, K | 97,906 | 26,526 | 92,672 | ||
| Annual Sales | 40,520,000 | 0 | 0 | ||
| Annual Net Income | -160,060,000 | -26,440,000 | -46,380,000 | ||
| Last Quarter Sales | 2,830,000 | 0 | 0 | ||
| Last Quarter Net Income | -24,980,000 | -6,050,000 | -5,680,000 | ||
| 60-Month Beta | 2.14 | -0.11 | 1.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 05/05/26 | -0.26 on 05/05/26 | -0.06 on 02/09/26 | ||
| Earnings Date | 08/11/26 | 08/04/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||